APA

Chang Y. S., Adnane J., Trail P. A., Levy J., Henderson A., Xue D., Bortolon E., Ichetovkin M., Chen C., McNabola A., Wilkie D., Carter C. A., Taylor I. C. A., Lynch M. & Wilhelm S. (20070522). Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. : Cancer chemotherapy and pharmacology.

Chicago

Chang Yong S, Adnane Jalila, Trail Pamela A, Levy Joan, Henderson Arris, Xue Dahai, Bortolon Elizabeth, Ichetovkin Marina, Chen Charles, McNabola Angela, Wilkie Dean, Carter Christopher A, Taylor Ian C A, Lynch Mark and Wilhelm Scott. 20070522. Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. : Cancer chemotherapy and pharmacology.

Harvard

Chang Y. S., Adnane J., Trail P. A., Levy J., Henderson A., Xue D., Bortolon E., Ichetovkin M., Chen C., McNabola A., Wilkie D., Carter C. A., Taylor I. C. A., Lynch M. and Wilhelm S. (20070522). Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. : Cancer chemotherapy and pharmacology.

MLA

Chang Yong S, Adnane Jalila, Trail Pamela A, Levy Joan, Henderson Arris, Xue Dahai, Bortolon Elizabeth, Ichetovkin Marina, Chen Charles, McNabola Angela, Wilkie Dean, Carter Christopher A, Taylor Ian C A, Lynch Mark and Wilhelm Scott. Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. : Cancer chemotherapy and pharmacology. 20070522.